当前位置: X-MOL 学术Crit. Care › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Early, biomarker-guided steroid dosing in COVID-19 Pneumonia: a pilot randomized controlled trial
Critical Care ( IF 15.1 ) Pub Date : 2022-01-04 , DOI: 10.1186/s13054-021-03873-2
Yewande E Odeyemi 1 , Sarah J Chalmers 1 , Erin F Barreto 2 , Jacob C Jentzer 3 , Ognjen Gajic 1 , Hemang Yadav 1
Affiliation  

ClinicalTrials.gov identifier (NCT number): NCT03852537 , Registered February 25, 2019.

中文翻译:

在 COVID-19 肺炎中早期、生物标志物指导的类固醇给药:一项试点随机对照试验

ClinicalTrials.gov 标识符(NCT 编号):NCT03852537,2019 年 2 月 25 日注册。
更新日期:2022-01-04
down
wechat
bug